Biomarkers

Microbiota-based biomarkers: We are ahead of the disease. Shop Our Services

What are biomarkers?

A biomarker is known as a molecule, organism or sequence of genetic material that acts as a specific indicator of a state of health or disease by being characteristic and specific for that specific situation.

How do we develop them at Bioithas?

Based on the study of the composition of the microbiota and the changes and alterations that occur in it in cases of stress for the organism, such as a disease, at Bioithas we identify, by means of currently growing techniques, such as massive sequencing, those microorganisms whose presence is altered (by excess or by default) compared to data from healthy people.    

The detection of these alterations in certain bacterial genera or species can be a great indicator of the state of a pathology, helping to directly improve its treatment.

Effective treatments in less time

Benefits of biomarkers

At Bioithas we are committed to the development of new biomarkers, which allow us to anticipate and respond to diseases early, which has a direct benefit for health, being able to apply the necessary treatments early. 

We currently have the patent for two predictive biomarkers for multiple sclerosis and head and neck cancer, diseases for which there is scientific evidence of alterations in the microbiota.  

Identify them

Types of biomarkers

· Depending on the nature of the molecule

There are different types of biomarkers depending on the nature of the molecule that is detected, for example: a metabolite, a protein, a DNA sequence or even a living organism.    

· Depending on your objective

Furthermore, they can also be classified by the objective of the biomarker itself, such as predictive biomarkers, which are used to know how a disease is going to evolve; tumor markers, which indicate the presence or future development of a tumor; and even toxicological markers, which are related to exposure to environmental toxins.  

At Bioithas, we focus, above all, on the development of predictive biomarkers for diagnosis, evolution and response to the treatment of diseases, based on the changes and alterations that occur in the microbiota (especially the intestinal one) as a cause or consequence of these pathologies .